Migergot Suppository
Product Images NDC 0713-0166

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Migergot (NDC 0713-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Maximum Adult Dosage: One Suppository At Start Of Attack; Second Suppository After 1 Hour, If Needed For Full Relief. Early Administration Gives Maximum Effectiveness. (0166administration)

This text appears to be a set of instructions for using suppositories to relieve an undefined ailment. The recommended dosage for adults is not clear, and there is a suggestion that a second suppository should be used if needed, after one hour. Administration is recommended rectally, and the instructions suggest that early administration is important for maximum effectiveness.*

FDA Label Image

Carton Label For Migergot®, Ergotamine Tartrate And Caffeine Suppositories Usp 12 Count (0166cartonlabel)

FDA Label Image

0166foil Back

This text does not provide enough information to generate a useful description as it consists of random characters and symbols. The text is likely a result of a low-quality scan.*

FDA Label Image

0166foil Front

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.